Blog
Psychedelic-assisted Therapy Using Ketamine for Cancer Patients
by PNI Experts
Cancer patients may find relief from mental anguish with ketamine-assisted therapy available at Saint John’s Health Center and Pacific Neuroscience Institute ® (PNI).
Vikki’s Path to Sobriety at the Treatment & Research In Psychedelics (TRIP) Program
by Amelia Garrison
After years of unsuccessful therapy, Vikki transformed her life for the better with psychedelic-assisted therapy at PNI's Pacific Treatment & Research In Psychedelics (TRIP). Learn more about her journey toward healing.
PNI Scientists Explore Using Psychedelics to Treat Alcohol, Drug Disorders
by Guest Author
Psilocybin and many other psychedelics are broadly prohibited under federal law. But US researchers at the PNI's Pacific Treatment & Research In Psychedelics (TRIP) program have been legally scrutinizing their use in a score of clinical trials.
PNI Founders’ Message 2023
by Daniel F. Kelly
At Pacific Neuroscience Institute® (PNI) we achieved many milestones in 2022 and continue to make positive impacts in neuroscience clinical care, research, and education.
PNI Publishes First-Ever Paper on Psychedelics in Neurosurgery and Neuro-oncology Literature
by PNI Experts
After a decades-long pause, psychedelics are once again being investigated for their transdiagnostic treatment potential. Discover the future of psychedelics in neurosurgery and neuro-oncology with experts from Pacific Neuroscience Institute ® (PNI).
What is Ketamine Therapy?
by Keith Heinzerling
Ketamine therapy is used to treat of depression, anxiety, PTSD, end-of-life distress, chronic pain, drug/alcohol problems, and more. Learn how it works.
Neurology and Neurosurgery High Level Performance Recognized at Providence Hospitals
by Zara Jethani
Pacific Neuroscience Institute teams in Neurology and Neurosurgery contribute to High Performing Hospitals in US News & World Report rankings.
Pacific Neuroscience Institute Physicians Named “L.A.’s Top Doctors” of 2022
by Zara Jethani
This year, six of Pacific Neuroscience Institute’s physicians were included in Los Angeles Magazine’s April 2022 roster of “L.A.’s Top Doctors.”
Psilocybin Clinical Trial for Depression Launches at Pacific Neuroscience Institute
by Zara Jethani
Pacific Neuroscience Institute (PNI) located at Providence Saint John's Health Center, has activated a new psilocybin clinical trial and has begun participant enrollment.
PNI Founders’ Message 2022
by Daniel F. Kelly
At Pacific Neuroscience Institute, we are looking forward to what lies ahead with fresh excitement. Neurological diseases do not stop and neither have we.
Last updated: January 18th, 2022